These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15460186)

  • 1. Nesiritide for treatment of heart failure due to right ventricular dysfunction.
    Sharp RP; Gregory A; Mowdy MH; Sirajuddin R
    Pharmacotherapy; 2004 Sep; 24(9):1236-40. PubMed ID: 15460186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
    Sica D; Oren RM; Gottwald MD; Mills RM;
    Clin Cardiol; 2010 Jun; 33(6):330-6. PubMed ID: 20556802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of nesiritide in pediatric heart failure.
    Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
    J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nesiritide in infants and children with congestive heart failure.
    Mahle WT; Cuadrado AR; Kirshbom PM; Kanter KR; Simsic JM
    Pediatr Crit Care Med; 2005 Sep; 6(5):543-6. PubMed ID: 16148814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.
    Owan TE; Chen HH; Frantz RP; Karon BL; Miller WL; Rodeheffer RJ; Hodge DO; Burnett JC; Redfield MM
    J Card Fail; 2008 May; 14(4):267-75. PubMed ID: 18474338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does nesiritide offer something new in the management of pediatric heart failure?
    Baden HP
    Pediatr Crit Care Med; 2005 Sep; 6(5):613-4. PubMed ID: 16148832
    [No Abstract]   [Full Text] [Related]  

  • 8. Nesiritide for the treatment of congestive heart failure.
    Iyengar S; Feldman DS; Trupp R; Abraham WT
    Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension.
    Kelesidis I; Mazurek JA; Saeed W; Chaudhari R; Velankar P; Zolty R
    Congest Heart Fail; 2012; 18(1):18-24. PubMed ID: 22277173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nesiritide in acute heart failure.
    Burger AJ; Silver MA
    Lancet; 2003 Sep; 362(9388):998; author reply 998-9. PubMed ID: 14511939
    [No Abstract]   [Full Text] [Related]  

  • 11. Nesiritide in acute heart failure.
    Drazner M; McGuire DK; de Lemos JA
    Lancet; 2003 Sep; 362(9388):998-9. PubMed ID: 14511940
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure.
    Lenz TL; Foral PA; Malesker MA; Hunter CB; Hilleman DE
    Pharmacotherapy; 2004 Sep; 24(9):1137-46. PubMed ID: 15460174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide: first use in India.
    Manchanda A; Kohli V
    Indian Heart J; 2009; 61(4):371-2. PubMed ID: 20635741
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
    Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
    Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nesiritide in critically ill children with biventricular dysfunction suffering from oliguria despite standard heart-failure management.
    Das BB; Koch J; Dimas V; Guleserian K; Nugent A
    Cardiol Young; 2016 Apr; 26(4):819-23. PubMed ID: 26694972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
    Kelesidis I; Mazurek J; Khullar P; Saeed W; Vittorio T; Zolty R
    Congest Heart Fail; 2012; 18(3):158-64. PubMed ID: 22497779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.